BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6153497)

  • 1. Comparative hemodynamic effects of converting enzyme inhibitor and sodium nitroprusside in severe heart failure.
    Vrobel TR; Cohn JN
    Am J Cardiol; 1980 Feb; 45(2):331-6. PubMed ID: 6153497
    [No Abstract]   [Full Text] [Related]  

  • 2. [New drug preparations used for treating congestive heart failure: converting enzyme inhibitors, nitroprusside, nitrates and calcium channel blockers].
    Rudolf W; Froer KL; Hall D
    Ter Arkh; 1982; 54(11):110-2. PubMed ID: 6186040
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative hemodynamic effects of intravenous nitroprusside and oral prazosin in refractory heart failure.
    Mehta J; Iacona M; Feldman RL; Pepine CJ; Conti CR
    Am J Cardiol; 1978 May; 41(5):925-30. PubMed ID: 645603
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiotensin converting enzyme inhibition in patients with congestive heart failure.
    Gavras H; Faxon DP; Berkoben J; Brunner HR; Ryan TJ
    Circulation; 1978 Nov; 58(5):770-6. PubMed ID: 699246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic effects of oral ephedrine given alone or combined with nitroprusside infusion in patients with severe left ventricular failure.
    Franciosa JA; Cohn JN
    Am J Cardiol; 1979 Jan; 43(1):79-85. PubMed ID: 758774
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibition in congestive heart failure: the concept.
    Cohn JN; Levine TB
    Am J Cardiol; 1982 Apr; 49(6):1480-3. PubMed ID: 6176108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central and peripheral hemodynamic effects of angiotensin inhibition in patients with refractory congestive heart failure.
    Faxon DP; Creager MA; Halperin JL; Gavras H; Coffman JD; Ryan TJ
    Circulation; 1980 May; 61(5):925-30. PubMed ID: 6153939
    [No Abstract]   [Full Text] [Related]  

  • 8. Central and regional hemodynamic effects of intravenous isosorbide dinitrate, nitroglycerin and nitroprusside in patients with congestive heart failure.
    Leier CV; Bambach D; Thompson MJ; Cattaneo SM; Goldberg RJ; Unverferth DV
    Am J Cardiol; 1981 Dec; 48(6):1115-23. PubMed ID: 6795915
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemodynamic effects of sodium nitroprusside in infants and children with large ventricular septal defect.
    Kunathai S; Ayuthya PS
    Pediatr Cardiol; 1989; 10(1):59. PubMed ID: 2704657
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of the vasodilator sodium nitroprusside in combination with digoxin in patients with refractory cardiac insufficiency].
    Mukharliamov NM; Grigor'iants RA; Naumov VG; Mareev VIu
    Ter Arkh; 1982; 54(5):128-31. PubMed ID: 7101175
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside.
    Pierpont GL; Cohn JN; Franciosa JA
    Chest; 1978 Jan; 73(1):8-13. PubMed ID: 620563
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiocirculatory effects of nitrates in the treatment of clinical congestive heart failure.
    Mason DT; Awan NA; DeMaria AN; Lee G; Amsterdam EA
    Herz; 1978 Dec; 63(36):387-98. PubMed ID: 400159
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients.
    Franciosa JA; Pierpont G; Cohn JN
    Ann Intern Med; 1977 Apr; 86(4):388-93. PubMed ID: 848799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal effects of nitroprusside and hydralazine in patients with congestive heart failure.
    Cogan JJ; Humphreys MH; Carlson CJ; Rapaport E
    Circulation; 1980 Feb; 61(2):316-23. PubMed ID: 7351056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined nitroprusside-dopamine therapy in severe chronic congestive heart failure. Dose-related hemodynamic advantages over single drug infusions.
    Stemple DR; Kleiman JH; Harrison DC
    Am J Cardiol; 1978 Aug; 42(2):267-75. PubMed ID: 685839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined therapy with digoxin and nitroprusside in heart failure complicating acute myocardial infarction.
    Raabe DS
    Am J Cardiol; 1979 May; 43(5):990-4. PubMed ID: 433783
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of refractory heart failure with infusion of nitroprusside.
    Guiha NH; Cohn JN; Mikulic E; Franciosa JA; Limas CJ
    N Engl J Med; 1974 Sep; 291(12):587-92. PubMed ID: 4855255
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemodynamic equivalence of automated nitroglycerin- and nitroprusside-infusions combined with dobutamine for augmentation of cardiac output in patients following aorta coronary bypass-operation.
    Pomer S; Sarai K; Krause E; Satter P
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):602-7. PubMed ID: 6437993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nitroprusside].
    Nobuyoshi M; Nosaka H
    Nihon Rinsho; 1978 Nov; 36(11):3583-92. PubMed ID: 366207
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitative differences in the hemodynamic effects of captopril and nitroprusside in severe chronic heart failure.
    Packer M; Meller J; Medina N; Yushak M
    Am J Cardiol; 1983 Jan; 51(1):183-8. PubMed ID: 6336876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.